(Q54069089)

24 May 2018

title

Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain. (English)

1 reference

24 May 2018

main subject

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

4

1 reference

24 May 2018

Carmen Torres

5

1 reference

24 May 2018

author name string

Portillo A

1

1 reference

24 May 2018

Lantero M

2

1 reference

24 May 2018

Gastañares MJ

3

1 reference

24 May 2018

publication date

1 October 1999

1 reference

24 May 2018

International Journal of Antimicrobial Agents

published in

1 reference

24 May 2018

volume

13

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

137-140

1 reference

24 May 2018

Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Different erythromycin resistance mechanisms in group C and group G streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Genetic manipulation of pathogenic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Erythromycin resistance in group A beta hemolytic streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Erythromycin resistance of Streptococcus pyogenes in Madrid.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Resistance to Erythromycin in Group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Erythromycin-resistant Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900104-1

7 January 2021

10.1016/S0924-8579(99)00104-1

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018